Literature DB >> 21412966

Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management.

Sang-Oh Lee1, Seung H Kang, Rima C Abdel-Massih, Robert A Brown, Raymund R Razonable.   

Abstract

Bacteremia is a significant cause of morbidity and mortality after liver transplantation. The characterization of the microbiological spectrum of bacteremia after liver transplantation may help physicians in choosing the initial empirical antimicrobial therapy for patients presenting with sepsis. The clinical and microbiology records of patients who received liver transplantation from January 1997 to March 2006 were reviewed. One hundred twenty-three of the 737 liver recipients (16.7%) developed bacteremia during the median follow-up period of 5.8 years (interquartile range = 2.5-8.8 years); 92 patients (12.5%) had gram-positive bacteremia (GPB), whereas 47 (6.4%) had gram-negative bacteremia (GNB). Nosocomial bacteremia was significantly more frequent among patients with early-onset GPB or GNB versus patients with late-onset GPB (66.7% versus 23.7%, P < 0.001) or GNB (70.6% versus 20.0%, P = 0.001). Peritonitis (33.3% versus 7.9%, P = 0.004) and wound infections (13.0% versus 0%, P = 0.04) as sources were more common in patients with early-onset GPB versus patients with late-onset GPB. Likewise, peritonitis was a more common source of early-onset GNB than late-onset GNB (41.2% versus 6.7%, P = 0.007). Staphylococcus aureus and Enterococcus faecium were the most common pathogens in patients with early-onset GPB, whereas Enterococcus faecalis and Streptococcus species were most common in patients with late-onset GPB. Pseudomonas aeruginosa and anaerobes were the most common pathogens in patients with early-onset GNB, whereas Escherichia coli was most common in patients with late-onset GNB. In conclusion, the microbiological spectra of early-onset and late-onset bacteremias differ, and this should be considered by those determining the initial empirical treatment of liver transplant recipients suspected to have bacteremias.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412966      PMCID: PMC3103629          DOI: 10.1002/lt.22296

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  14 in total

1.  Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

Authors:  Sung-Han Kim; Wan-Bum Park; Ki-Deok Lee; Cheol-In Kang; Hong-Bin Kim; Myoung-don Oh; Eui-Chong Kim; Kang-Won Choe
Journal:  Clin Infect Dis       Date:  2003-08-23       Impact factor: 9.079

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections.

Authors:  N Deborah Friedman; Keith S Kaye; Jason E Stout; Sarah A McGarry; Sharon L Trivette; Jane P Briggs; Wanda Lamm; Connie Clark; Jennifer MacFarquhar; Aaron L Walton; L Barth Reller; Daniel J Sexton
Journal:  Ann Intern Med       Date:  2002-11-19       Impact factor: 25.391

4.  Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression.

Authors:  N Singh; T Gayowski; M M Wagener; I R Marino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

5.  Bloodstream infection after living donor liver transplantation.

Authors:  Masao Hashimoto; Yasuhiko Sugawara; Sumihito Tamura; Junichi Kaneko; Yuichi Matsui; Junichi Togashi; Masatoshi Makuuchi
Journal:  Scand J Infect Dis       Date:  2008

6.  High mortality related with Staphylococcus aureus bacteremia after liver transplantation.

Authors:  J Torre-Cisneros; C Herrero; E Cañas; J M Reguera; M De La Mata; M A Gómez-Bravo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-05-08       Impact factor: 3.267

7.  Surgical site infection in living-donor liver transplant recipients: a prospective study.

Authors:  Yoshitsugu Iinuma; Kazuyoshi Senda; Naoko Fujihara; Takashi Saito; Shunji Takakura; Toyoichiro Kudo; Tetsuya Kiuchi; Koichi Tanaka; Satoshi Ichiyama
Journal:  Transplantation       Date:  2004-09-15       Impact factor: 4.939

8.  Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens.

Authors:  Nina Singh; Marilyn M Wagener; Asia Obman; Thomas V Cacciarelli; Michael E de Vera; Timothy Gayowski
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

9.  Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience.

Authors:  Y J Kim; S I Kim; S H Wie; Y R Kim; J A Hur; J Y Choi; S K Yoon; I S Moon; D G Kim; M D Lee; M W Kang
Journal:  Transpl Infect Dis       Date:  2008-05-26       Impact factor: 2.228

Review 10.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

View more
  24 in total

Review 1.  Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.

Authors:  Nursel Calik Basaran; Sibel Ascioglu
Journal:  Ther Adv Infect Dis       Date:  2017-10-17

2.  Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome.

Authors:  Patricia I Diaz; Bo-Young Hong; Jorge Frias-Lopez; Amanda K Dupuy; Mark Angeloni; Loreto Abusleme; Evimaria Terzi; Effie Ioannidou; Linda D Strausbaugh; Anna Dongari-Bagtzoglou
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

Review 3.  Bacterial infection after liver transplantation.

Authors:  Sang Il Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

4.  Analysis of infections in the first 3-month after living donor liver transplantation.

Authors:  Chuan Li; Tian-Fu Wen; Kai Mi; Chuan Wang; Lu-Nan Yan; Bo Li
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

5.  Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases.

Authors:  Jiandang Zhou; Hui Huang; Shan Liu; Ping Yu; Qiquan Wan
Journal:  Ther Clin Risk Manag       Date:  2015-06-12       Impact factor: 2.423

6.  Epidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipients.

Authors:  Hyun Kyung Kim; Yong Keun Park; Hee-Jung Wang; Bong Wan Kim; So Youn Shin; Seung-Kwan Lim; Young Hwa Choi
Journal:  Infect Chemother       Date:  2013-09-27

7.  Methicillin-Resistant Staphylococcus aureus Prostatic Abscess in a Liver Transplant Recipient.

Authors:  Tanima Jana; Jorge D Machicado; Giovanni E Davogustto; Jen-Jung Pan
Journal:  Case Rep Transplant       Date:  2014-10-20

8.  Predictors of mortality in solid-organ transplant recipients with infections caused by Acinetobacter baumannii.

Authors:  Hua Liu; Qifa Ye; Qiquan Wan; Jiandang Zhou
Journal:  Ther Clin Risk Manag       Date:  2015-08-21       Impact factor: 2.423

9.  Changes in Surgical Site Infections after Living Donor Liver Transplantation.

Authors:  Masaki Yamamoto; Shunji Takakura; Yoshitsugu Iinuma; Go Hotta; Yasufumi Matsumura; Aki Matsushima; Miki Nagao; Kohei Ogawa; Yasuhiro Fujimoto; Akira Mori; Yasuhiro Ogura; Toshimi Kaido; Shinji Uemoto; Satoshi Ichiyama
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

10.  Prognostic and diagnostic value of procalcitonin in the post-transplant setting after liver transplantation.

Authors:  Aristotelis Perrakis; Falk Stirkat; Roland S Croner; Nikolaos Vassos; Dimitrios Raptis; Süleyman Yedibela; Werner Hohenberger; Volker Müller
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.